Public stock offering pulls in $22.6M for InspireMD

04/23/2013 | MassDevice.com (Boston)

InspireMD has secured net proceeds of $22.6 million in a public offering of company shares. The Israeli device firm will use part of the funding to seek FDA approval of its MGuard carotid and coronary stents, which are used to prevent the risk of embolism in patients who have undergone stenting procedures.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX